Hideki Shimura

6.8k total citations · 2 hit papers
83 papers, 5.3k citations indexed

About

Hideki Shimura is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Hideki Shimura has authored 83 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Neurology, 19 papers in Molecular Biology and 16 papers in Cellular and Molecular Neuroscience. Recurrent topics in Hideki Shimura's work include Parkinson's Disease Mechanisms and Treatments (23 papers), Ubiquitin and proteasome pathways (9 papers) and Neurological disorders and treatments (8 papers). Hideki Shimura is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (23 papers), Ubiquitin and proteasome pathways (9 papers) and Neurological disorders and treatments (8 papers). Hideki Shimura collaborates with scholars based in Japan, United States and Australia. Hideki Shimura's co-authors include Nobutaka Hattori, Yoshikuni Mizuno, Kenneth S. Kosik, Shuichi Asakawa, Satoshi Minoshima, Shinichiro Kubo, Nobuyoshi Shimizu, Toshiaki Suzuki, Keiji Tanaka and Tomoki Chiba and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Hideki Shimura

81 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

2000 1.6k citations Hideki Shimura, Nobutaka Hattori et al. Nature Genetics profile →
Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease

2001 842 citations Hideki Shimura, Michael G. Schlossmacher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hideki Shimura Japan	29	2.5k	2.2k	1.7k	1.1k	915	83	5.3k
Fumiaki Mori Japan	50	4.2k 1.7×	2.2k 1.0×	2.2k 1.3×	1.5k 1.3×	785 0.9×	212	7.2k
Koichi Okamoto Japan	41	2.3k 0.9×	2.1k 1.0×	1.0k 0.6×	1.5k 1.4×	443 0.5×	216	5.5k
Kunikazu Tanji Japan	42	2.4k 0.9×	1.9k 0.9×	1.2k 0.7×	1.2k 1.0×	759 0.8×	152	5.0k
Paul Lingor Germany	43	1.7k 0.7×	2.5k 1.1×	1.8k 1.1×	963 0.9×	474 0.5×	154	5.7k
Olga Corti France	34	1.7k 0.7×	2.1k 1.0×	1.1k 0.7×	816 0.7×	1.1k 1.3×	63	4.0k
Clemens R. Scherzer United States	35	1.8k 0.7×	1.8k 0.8×	1.2k 0.7×	1.6k 1.4×	571 0.6×	72	4.5k
Minh Dang Nguyen Canada	32	1.5k 0.6×	2.5k 1.1×	1.1k 0.6×	940 0.8×	298 0.3×	70	5.7k
Miratul M. K. Muqit United Kingdom	34	2.5k 1.0×	3.4k 1.6×	1.3k 0.8×	1.2k 1.1×	2.6k 2.9×	63	6.2k
Leslie Crews United States	49	2.4k 0.9×	3.1k 1.4×	2.1k 1.2×	3.2k 2.8×	435 0.5×	90	8.8k
Takahiko Tokuda Japan	42	3.3k 1.3×	2.3k 1.1×	1.5k 0.9×	2.5k 2.2×	496 0.5×	171	6.9k

Countries citing papers authored by Hideki Shimura

Since Specialization

Citations

This map shows the geographic impact of Hideki Shimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Shimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Shimura more than expected).

Fields of papers citing papers by Hideki Shimura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Shimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Shimura. The network helps show where Hideki Shimura may publish in the future.

Co-authorship network of co-authors of Hideki Shimura

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Shimura. A scholar is included among the top collaborators of Hideki Shimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Shimura. Hideki Shimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hira, Kenichiro, Hideki Shimura, Masashi Takanashi, et al.. (2019). Multiple cerebral infarction diagnosed as Eosinophilic Granulomatosis with Polyangiitis by autopsy. BMC Neurology. 19(1). 288–288. 6 indexed citations

Shimada, Yoshiaki, Hideki Shimura, Ryota Tanaka, et al.. (2018). Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator. PLoS ONE. 13(5). e0198039–e0198039. 14 indexed citations

Shimura, Hideki, Ryota Tanaka, Yoshiaki Shimada, et al.. (2017). Glycyl-alanyl-histidine protects PC12 cells against hydrogen peroxide toxicity. BMC Biochemistry. 18(1). 14–14. 4 indexed citations

Nagayama, Hiroshi, Tetsuya Maeda, Tsuyoshi Uchiyama, et al.. (2016). Anhedonia and its correlation with clinical aspects in Parkinson's disease. Journal of the Neurological Sciences. 372. 403–407. 24 indexed citations

Ochiishi, Tomoyo, Motomichi Doi, Kazuhiko Yamasaki, et al.. (2016). Development of new fusion proteins for visualizing amyloid-β oligomers in vivo. Scientific Reports. 6(1). 22712–22712. 36 indexed citations

Shimada, Yoshiaki, Ryota Tanaka, Hideki Shimura, et al.. (2014). Phosphorylation enhances recombinant HSP27 neuroprotection against focal cerebral ischemia in mice. Neuroscience. 278. 113–121. 21 indexed citations

Tanaka, Ryota, Yuji Ueno, Nobukazu Miyamoto, et al.. (2013). Impact of diabetes and prediabetes on the short-term prognosis in patients with acute ischemic stroke. Journal of the Neurological Sciences. 332(1-2). 45–50. 66 indexed citations

Mori, Akio, Yasunobu Hoshino, Hideki Shimura, et al.. (2013). Motor-dominant polyneuropathy due to IgM monoclonal antibody against disialosyl gangliosides in a patient with mantle cell lymphoma. Journal of the Neurological Sciences. 337(1-2). 215–218. 5 indexed citations

Shimura, Hideki, Ryota Tanaka, Takao Urabe, Shigeki Tanaka, & Nobutaka Hattori. (2011). Art and Parkinson’s disease: a dramatic change in an artist’s style as an initial symptom. Journal of Neurology. 259(5). 879–881. 17 indexed citations

10.

Tanaka, Ryota, Hideki Shimura, Yasutaka Tanaka, et al.. (2010). Economy Class Stroke Syndrome after a Long Drive. Journal of Stroke and Cerebrovascular Diseases. 21(2). 155–157. 2 indexed citations

11.

Shimura, Hideki, Ryota Tanaka, Hideo Mori, et al.. (2009). Excitatory amino acid transporter 2 associates with phosphorylated tau and is localized in neurofibrillary tangles of tauopathic brains. FEBS Letters. 583(13). 2194–2200. 20 indexed citations

12.

Miyamoto, Nobukazu, Ryota Tanaka, Hideki Shimura, et al.. (2009). Crucial role for Ser133-phosphorylated form of cyclic AMP-responsive element binding protein signaling in the differentiation and survival of neural progenitors under chronic cerebral hypoperfusion. Neuroscience. 162(2). 525–536. 27 indexed citations

13.

Shimura, Hideki, et al.. (2006). NKG2D Ligation without T Cell Receptor Engagement Triggers Both Cytotoxicity and Cytokine Production in Dendritic Epidermal T Cells. Journal of Investigative Dermatology. 126(5). 1052–1058. 54 indexed citations

14.

Schlossmacher, Michael G. & Hideki Shimura. (2005). Parkinson's Disease: Assays for the Ubiquitin Ligase Activity of Neural Parkin. Humana Press eBooks. 301. 351–370. 10 indexed citations

15.

Schlossmacher, Michael G., Matthew P. Frosch, Wei Gai, et al.. (2002). Parkin Localizes to the Lewy Bodies of Parkinson Disease and Dementia with Lewy Bodies. American Journal Of Pathology. 160(5). 1655–1667. 255 indexed citations

16.

Minagawa, Masahiro, Hisami Watanabe, Chikako Miyaji, et al.. (2002). Enforced Expression of Bcl-2 Restores the Number of NK Cells, But Does Not Rescue the Impaired Development of NKT Cells or Intraepithelial Lymphocytes, in IL-2/IL-15 Receptor β-Chain-Deficient Mice. The Journal of Immunology. 169(8). 4153–4160. 48 indexed citations

17.

Tanaka, Keiji, Toshiaki Suzuki, Tomoki Chiba, et al.. (2001). Parkin is linked to the ubiquitin pathway. Journal of Molecular Medicine. 79(9). 482–494. 57 indexed citations

18.

Hattori, Nobutaka, Hideki Shimura, Shinichiro Kubo, et al.. (2000). Autosomal recessive juvenile parkinsonism: A key to understanding nigral degeneration in sporadic Parkinson's disease. Neuropathology. 20(s1). 85–90. 21 indexed citations

19.

Hattori, Nobutaka, Hideki Shimura, S. Kubo, et al.. (2000). Importance of familial Parkinson’s disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson’s disease. PubMed. 101–116. 15 indexed citations

20.

Shimura, Hideki, Nobutaka Hattori, Shinichiro Kubo, et al.. (2000). Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nature Genetics. 25(3). 302–305. 1602 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact